These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1751872)

  • 1. Neuroleptic malignant syndrome secondary to loxapine.
    Chong LS; Abbott PM
    Br J Psychiatry; 1991 Oct; 159():572-3. PubMed ID: 1751872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome.
    Irwin GE; Simon JE
    J Emerg Med; 1984; 1(3):207-11. PubMed ID: 6491238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome associated with withdrawal from carbamazepine.
    Keepers GA
    Am J Psychiatry; 1990 Dec; 147(12):1687. PubMed ID: 2244648
    [No Abstract]   [Full Text] [Related]  

  • 4. [Loxapine succinate: a new neuroleptic].
    Cottereau MJ; Poirier MF; Lôo H; Deniker P
    Encephale; 1979; 5(3):251-67. PubMed ID: 39739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome: case report and discussion.
    Chandran GJ; Mikler JR; Keegan DL
    CMAJ; 2003 Sep; 169(5):439-42. PubMed ID: 12952806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Neuroleptic malignant syndrome associated with quetiapine.
    Karagianis J; Phillips L; Hogan K; LeDrew K
    Can J Psychiatry; 2001 May; 46(4):370-1. PubMed ID: 11387795
    [No Abstract]   [Full Text] [Related]  

  • 7. An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: report of a case and results of a clozapine rechallenge.
    Goates MG; Escobar JI
    J Clin Psychopharmacol; 1992 Apr; 12(2):139-40. PubMed ID: 1573039
    [No Abstract]   [Full Text] [Related]  

  • 8. Loxapine succinate as a neuroleptic agent: evaluation in two populations of elderly psychiatric patients.
    Branchey MH; Lee JH; Simpson GM; Elgart B; Vicencio A
    J Am Geriatr Soc; 1978 Jun; 26(6):263-7. PubMed ID: 757995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist intervention to detect drug adverse events on admission to the emergency department: Two case reports of neuroleptic malignant syndrome.
    Leenhardt F; Perier D; Pinzani V; Giraud I; Villiet M; Castet-Nicolas A; Gourhant V; Breuker C
    J Clin Pharm Ther; 2017 Aug; 42(4):502-505. PubMed ID: 28488314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the predisposition to neuroleptic malignant syndrome genetically transmitted?
    Otani K; Horiuchi M; Kondo T; Kaneko S; Fukushima Y
    Br J Psychiatry; 1991 Jun; 158():850-3. PubMed ID: 1678666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome with trifluperidol.
    Singh SP; Giridhar C; Avasthi A
    Br J Psychiatry; 1989 Oct; 155():561-3. PubMed ID: 2611583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and NMS.
    Buckley PF; Meltzer HY
    Br J Psychiatry; 1993 Apr; 162():566. PubMed ID: 8329060
    [No Abstract]   [Full Text] [Related]  

  • 17. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success of tardive electroconvulsive therapy sessions after loxapine-induced malignant syndrome in the context of very poor metabolisation.
    Descoeur J; Philibert L; Chalard K; Attal J; Petit P; Klouche K; Olivier M
    Therapie; 2017 Dec; 72(6):643-647. PubMed ID: 28647110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.